Skip to content

The Archive · A Source

COMPASS Pathways initiates UK component of global phase 3 study of psilocybin treatment in treatment-resistant depression

Compass Pathways 2023 ir.compasspathways.com/News--Events-/news/news-details/2023/Compass-Pathways-initiates-UK-component-of-global-phase-3-study-of-psilocybin-treatment-in-treatment-resistant-depression-and-launches-new-research-center/default.aspx